[1]
V. Shapovalova, “Pharmacotherapy of Depressive Disorders in Conditions of Coronavirus Disease: Pharmacoeconomic Experimental Study”, SSPMPM, vol. 3, no. 3, pp. 1–11, Jul. 2023.